2-Hydroxymyristic acidAlternative Names: 2-HM; 2-Hydroxytetradecanoic acid
Latest Information Update: 10 Jul 2002
At a glance
- Originator BTG
- Class Antivirals
- Mechanism of Action Myristoyl transferase inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Viral infections
Most Recent Events
- 29 Jul 1999 2-Hydroxymyristic acid is available for licensing (http://www.btg.co.uk/technologies/anti_infectives.asp)
- 29 Jul 1999 New profile
- 29 Jul 1999 Preclinical development for Viral infections in United Kingdom (Unknown route)